alexa Chemiluminescent Enzyme Immunoassay

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Chemiluminescent Enzyme Immunoassay

The high plasma concentration of TF observed in patients with malignant diseases may have a major role in the elevated risk of thrombosis in these patients. The quantification of plasma TF-bearing micro particles in cancer patients may enable an accurate assessment of the risk of thrombosis during the process of cancer progression. Pancreatic cancer patients have a strong likelihood of developing cancer-associated thrombosis, compared with healthy volunteers

Citation:

Fujiwara Y, Koga Y, Hasegawa K, Fujii H, Yamaguchi T, et al. (2014) A New Chemiluminescent Enzyme Immunoassay for Plasma Tissue Factor Detection. Biosens J 3:111.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top